HEAL.JK Earnings — PT Medikaloka Hermina Tbk
JKT
Updated
When is HEAL.JK's next earnings date?
PT Medikaloka Hermina Tbk (HEAL.JK) has not announced its next earnings date yet. Its most recent earnings report was on Tuesday, October 27, 2026.
How did HEAL.JK do in its last earnings report?
In its most recent report on Oct 27, 2026, PT Medikaloka Hermina Tbk posted EPS of $7.22. Revenue was $1.91T against a $1.94T estimate.
About PT Medikaloka Hermina Tbk
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, plastic and reconstructive surgery, neurosurgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, primary care family medicine, nuclear medicine and molecular theranostics, psychiatry, andrology, dietetics, lactation counseling, and dermatology and venereology. It also provides services in the areas of ophthalmology, clinical microbiology, pediatric neurology, occupational, radiation oncology, orthopedics and traumatology, pulmonology, anatomical pathology, clinical pathology, anesthesiology, internal medicine, psychology, radiology, physical medicine and rehabilitation, neurology, sports medicine specialist, aviation specialist, radiation specialist, otorhinolaryngology, occupational therapy, and urology. In addition, the company offers digital subtraction angiography, gastroenterology, IVF clinic, sleep and snoring clinic, pain clinic, growth and development clinic, stem cell, palliative care, perinatology ward, integrated stroke, and medical tourism services. Further, it is involved in investment, service, trading, management consulting, nurse training, and education services. PT Medikaloka Hermina Tbk was founded in 1985 and is headquartered in Jakarta Timur, Indonesia.
🤖 AI Earnings Analysis
HEAL.JK trades at 19.1× earnings with a 6.02% profit margin; without recent news or guidance data, valuation alone offers limited evidence of near-term upside.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | — | 7.22 | — | $1914.00B | — | — | — | — | |
| 2026-07-29 | — | 6.02 | — | $1826.00B | — | — | — | — |
Showing last 2 quarters.